What Happened?
Cambridge, MA-based Sage-Therapeutics Appointed Erin Lanciani as Senior Vice President, People and Organizational Strategy
Date of management change: April 15, 2016
Cambridge, MA-based Sage-Therapeutics Appointed Erin Lanciani as Senior Vice President, People and Organizational Strategy
Sage Therapeutics is a clinical-stage biopharmaceutical company committed to developing novel medicines to transform the lives of patients with life-altering central nervous system (CNS) disorders. Sage`s lead product candidate, ZULRESSO(TM) (brexanolone) injection, has completed Phase 3 clinical development for postpartum depression and a New Drug Application is currently under review with the U.S. Food and Drug Administration. Sage is developing a portfolio of novel product candidates targeting critical CNS receptor systems, including SAGE-217, which is in Phase 3 development in major depressive disorder and postpartum depression.
Erin Lanciani is Chief People and Experience Officer at Sage Therapeutics. Previously, Erin held various senior HR leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: McRoberts Trisha, Oswald Rachael, Ross Andrew, Harrell Sylvia, Logan Lisa, Whealon Lisa, Arefi Yousef, Walsh Neal, Pattabhiraman Arun, Jaynes Clint, McKissock Hunter
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.